Introduction

The support of blood flow is one of the central goals of clinical medicine, and the understanding of the regulation of blood flow is the sine qua non of cardiac physiology. Building on the foundational work of Frank and Starling, Arthur Guyton proposed that characteristics of the venous circulation were of fundamental importance in the regulation of cardiac output and thus blood flow. However, several authors have raised strong objections to Guyton's model, and more than 50 years after the publication of his model, there is still debate about whether Guyton's ideas present a viable model of cardiac control or whether several fundamental misjudgments lie at the core of Guyton's conclusions [14].

A brief history of cardiac output

Traditionally, the heart's accepted role has been that it not only provides the driving force for blood flow but also determines the total blood flow [57]. Simply stated, cardiac output is the product of stroke volume and heart rate. In this view, all pressures in the heart and circulatory system (for example, those measured in the large veins, in the cardiac chambers, and in the arteries) are derivatives of the force generated by the heart rather than independent variables that might have an influence on the heart's function and thus cardiac output.

At the end of the 19th century, Frank [8] found that ventricular contractility was increased if the ventricle was stretched prior to contraction. Building on this observation, Starling and colleagues [9, 10] found that increasing venous return increased stroke volume. We therefore term the ability of the heart to change its force of contraction (and stroke volume) in response to changes in venous return the Frank-Starling mechanism.

The ventricle does not operate on a single Frank-Starling curve. Any heart may operate on a family of curves, each of which is defined by the afterload, inotropic state, and diastolic compliance of the heart. Changes in venous return cause the ventricle to move along a single Frank-Starling curve that is defined by the existing conditions of afterload and inotropy and diastolic compliance.

Guyton's observations and model

Guyton felt that three factors were central in the determination of cardiac output: the pumping function of the heart, the resistance to blood flow through the peripheral circulation, and the degree of filling of the circulatory system with blood [11].

The heart's permissive role in the determination of cardiac output

If, Guyton reasoned, cardiac output is governed solely by heart function, then changing either heart rate or the heart's pumping ability should change cardiac output [12]. Extending the observations of Brauwald and colleagues [13] that cardiac output was largely unaffected by heart rate when subjects were electrically paced, Guyton electrically paced the hearts of dogs that had a surgically created arteriovenous fistula between the aorta and the inferior vena cava [14]. Prior to the opening of this fistula, changes in heart rate had no effect on cardiac output. However, when the fistula was opened (causing increased preload as evidenced by high right atrial pressure [PRA] values), cardiac output increased in proportion to heart rate changes. The advent of extra-corporeal circuits allowed Guyton to question whether the intrinsic pumping ability or contractility of the heart was the sole determinant of cardiac output [15]. When the pump speed of the extracorporeal circuit was increased, cardiac output did not increase significantly. However, by increasing the pump speed enough to lower PRA to zero, the thoracic veins collapsed, thereby limiting flow. From these observations, Guyton concluded that at steady state the heart played a permissive role. In Guyton's model, the heart will pump as much blood as is presented to it, within the limits of intrinsic contractility and heart rate. To demonstrate this, Guyton and colleagues [16, 17] increased the blood volume of dogs by 30% to 40% over several minutes by venous transfusion. In all animals, cardiac output initially doubled and remained approximately 20% above pre-transfusion levels. Guyton had shown that, independently of heart rate, intravenous volume increases profoundly affected cardiac output.

Factors peripheral to the heart determine cardiac output

Guyton felt that, in addition to heart function, characteristics of the peripheral circulation (and particularly the venous circulation) played a central role in determining cardiac output. The two key descriptors of the peripheral circulation that Guyton felt were critical to the understanding of cardiac output were PRA and 'mean circulatory filling pressure' (MCFP).

PRA as a determinant of cardiac output was not a novel concept. Demonstrating this relationship in intact subjects is difficult because of the numerous compensatory events that occur in response to any change in PRA or cardiac output. To overcome this, Guyton performed rapid transfusions of anesthetized dogs that had previously damaged myocardium or that were receiving epinephrine infusions. PRA can also be seen as an impediment to the flow of venous blood into the right atrium. If PRA impedes flow, what drives flow? To answer this, Guyton proposed a novel concept: mean circulatory filling pressure [18].

Mean circulatory filling pressure

Whereas Weber coined the term 'statischer Fullungs druck' ('static filling pressure'), Guyton made 'mean circulatory filling pressure' a central component of his model [19]. Earlier authors had recognized some of the concepts contained within it [1921]. MCFP represents the average integrated pressure throughout the circulatory system. It can be measured by stopping blood flow and allowing the pressures throughout the circulatory system to reach equilibrium. It may be thought of as a measure of the elastic recoil potential stored in the walls of the entire circulatory system (including the heart and pulmonary circulation). As such, it is a function of the volume of fluid within the system and the capacitance of the system. As more fluid enters the circulatory system (such as during transfusion), the MCFP increases because the elastic energy within the system increases. In contrast, increasing the capacitance of the system (due to vessel wall relaxation) will decrease MCFP.

Mean systemic filling pressure (MSFP), though often confused with MCFP and often similar in value, is different. MSFP represents the pressure generated by elastic recoil in the systemic circulation during a no-flow state. MSFP can be affected by the distribution of flow and volume prior to stopping circulation (for example, it will be higher in procedures that obstruct right heart inflow prior to measurement than in those that do not) [22].

MCFP, and not the arterial pressure generated by the heart, is what drives the flow of blood toward the right atrium in Guyton's model. It is MCFP that overcomes venous resistance and PRA. The net driving pressure for venous return to the heart was described by the difference between MCFP and PRA. This concept has often been taught by using a bathtub analogy originally proposed by Magder and colleagues [23, 24].

The rate at which a bathtub empties is a function of the height of water above the drain in the tub and the tub drain's characteristics, which include the resistance to flow and the pressure downstream of the drain. In this analogy, the inflow of water from the tap may be thought of as arterial pressure and flow, the level of water in the tub as MCFP (the elastic recoil in the system), and the drain as the venous resistance to flow and PRA. The 'force' of flow from the tap (arterial pressure) into the tub does not directly affect drainage beyond increasing the level of water in the tub. It is the elastic recoil of the systemic vessels (both veins and arteries) that determines flow in the systemic circulation. If the downstream pressure is the same as the pressure in the tub, the tub will not empty. Analogously, when the pressure downstream (PRA) is equal to MCFP, there is no flow; flow can occur only when MCFP is greater than PRA.

What controls mean circulatory filling pressure?

If venous return to the heart and thus cardiac output are dependent on MCFP, the question then is, what controls MCFP? It is not explicitly stated in Guyton's early work but it became obvious in his later writing [12] that he believed that resistance and capacitance at the organ and muscle levels were the central issue. During periods of increased oxygen demand (exercise, fever, increased metabolism), the affected organs would release unidentified mediators that cause vasodilation in their local vascular beds.

This concept is similar to both Krogh's and Caldini's two-compartment model of venous return [2528], wherein the systemic circulation consists of (at least) two parallel compartments with different venous time constants. In the short time constant, blood moves quickly from the arterial system through the vascular bed into the venous circulation with little resistance. In the long time constant, compartment transit through the vascular bed takes longer, and less blood is available to fill the venous circulation. An increase in the proportion of blood flow through the fast time constant compartment would cause a net decrease in the total transit time of blood flow into the venous system. Thus, the re-distribution of cardiac output to the short time constant circulation from the long time constant circulation during exercise or illness might increase venous return and thus cardiac output [29].

Venous return and cardiac output depend on mean circulatory filling pressure

To investigate the effect of MCFP and PRA on venous return, Guyton and colleagues [15] cannulated the right atria of 15 anesthetized dogs. This cannula was attached to a motorized pump, and the output cannula was placed in the proximal aorta. MCFP was varied by altering the amount of fluid in the circulatory system, and PRA was altered by changing the pump speed. To alter PRA, Guyton adjusted the height of the Starling resistor relative to heart level, keeping the resistor in a state of partial collapse. PRA was therefore established by the length of the hydrostatic column between the level of the resistor and the level of the atrium. MCFP was determined by stopping the circulation (pump) and measuring pressures once arterial and venous pressures had come to equilibrium. Using this model, Guyton was able to describe the first of his now famous 'venous return curves' (Figure 1). Guyton felt this demonstrated that the rate of venous return is dependent on both the characteristics of the peripheral circulation (MCFP) and the impedance to venous return (PRA).

Figure 1
figure 1

Relationship between right atrial pressure and venous return when mean circulatory filling pressure (MCFP) was held constant at different levels. Redrawn from Guyton [30].

Clinical utility of Guyton's model

Guyton recognized that, during steady-state physiology, venous return must equal cardiac output and that one therefore could relate cardiac output directly to the determinants of venous return. This was achieved by graphically superimposing venous return curves on cardiac function curves. By combining cardiac function curves with venous return curves (Figure 1) in a single diagram (Figure 2), Guyton could display the inter-relationships between PRA, MCFP, venous return, and cardiac output. The power of this combined model of cardiac output and venous return is perhaps best demonstrated through the evaluation of several clinical scenarios.

Figure 2
figure 2

Cardiac function curves can be superimposed on venous return curves. Cardiac function curves (green, blue, and red lines) depict the heart function under different conditions. Venous return curves (grey lines) represent normal, decreased, and increased values of mean circulatory filling pressure (MCFP). Redrawn and modified from Guyton [30].

The normal state and acute volume transfusion

In Figure 2 the intersection of the cardiac output curve and the venous return curve of a normal subject occurs at a single intercept: point A, where PRA is approximately zero. With acute transfusion, MCFP will increase. We can see the effect that this will have on cardiac output by looking at the intercept of this new venous return curve ('increased MCFP') with the normal cardiac output curve: point B, which has a higher associated cardiac output. Thus, the model has predicted that increasing MCFP by volume infusion will increase cardiac output without an alteration in intrinsic cardiac function -- exactly as Guyton's experiments demonstrated [30].

Acute hemorrhage or vasodilatory shock

In normal subjects, decreasing intravascular volume will decrease MCFP and generate a new venous return curve ('decreased MCFP' in Figure 2). If there is no change in cardiac function, the new intercept (point C) predicts a lower cardiac output. Likewise, if MCFP is changed by increasing capacitance (as in sepsis) rather than by decreasing volume, the same result occurs. In both situations, the solution is suggested by Guyton's diagram: by increasing MCFP (by infusing volume or decreasing capacitance with vasoconstrictors), the patient can be returned to normal cardiac output (point A).

Recent research and clinical guidelines have promoted early goal-directed therapy (EGDT) as a useful paradigm for the resuscitation of patients with severe sepsis or septic shock. A central strategy in EGDT is to maintain central venous pressure (CVP) between 8 and 12 mm Hg - purportedly to improve cardiac output [31]. Despite the widespread belief that CVP reflects the adequacy of cardiac preload in critically ill patients, there is a large body of evidence suggesting that the relationship between CVP and cardiac output is tenuous [32]. Rather, CVP represents the interaction between pump function and venous return and can give meaningful information about volume status if some measurement of cardiac function is known [33].

Heart failure

With decreasing cardiac function in a normal subject (as after myocardial infarction), Guyton's model predicts that if MCFP is unchanged, cardiac output will decrease (point D). Interestingly, the model also predicts that PRA will increase. Again, solutions are suggested by the model. Either increasing cardiac function (via inotropic medications or mechanical support devices) or increasing MCFP (via volume infusion or venoconstrictors) will return the subject to a normal cardiac output: points A and E, respectively. However, the model predicts that this will occur at different values of PRA. The clinical examples above demonstrate the power of Guyton's model of cardiac output. The ability to clearly explain and predict the outcomes of manipulating the various factors of vascular and cardiac function has led to the wide adoption and acceptance of Guyton's model.

Criticisms of Guyton's model

Criticisms of the model fall into one of two main categories: (a) that the experiments upon which Guyton's conclusions were based do not reflect physiologic reality or (b) that the conclusions drawn are flawed. The central criticism of Guyton's experiments involves the physical experimental model used to demonstrate the relationship between PRA, MCFP, and venous return and changes in cardiac output [1, 5]. In Guyton's original paper, this is not described. In subsequent publications [15, 30, 34], it appears that the researchers adjusted pump output to control PRA 'by increasing or decreasing the minute capacity of the pump' [30]. One interpretation [5] of these statements is that the researchers actively adjusted the pump after each change in elevation of the Starling resistor to obtain the desired state of partial collapse of the resistor tubing. If this is so, Brengelmann [1] suggests, it raises substantial questions about the model used. A central argument of Guyton's model is that PRA controls cardiac output. If the researchers changed the pump speed based on the height of the Starling resistor, this experimental model operated in a fashion that is opposite to Guyton's theory and it was actually pump speed (that is, cardiac output) that controlled PRA.

It is, however, difficult to imagine how else to test this model, proponents of Guyton's model might suggest. The model of Caldini and colleagues [26] identifies three partial differentials needed to resolve the authors' equation for the vasculature: cardiac output, PRA, and stressed volume. It is necessary to hold one of these variables constant to assess the relationship between the other two. Thus, to assess the effect of volume on cardiac output/venous return, PRA must be held constant. Within the experimental model used by Guyton, this required that pump speed change.

The other broad criticism of Guyton's model is that it contains misinterpretations of the original experimental data, specifically that data generated from several static measurements have been interpreted as describing the dynamics of venous return and cardiac output.

Critics of venous return curves argue that the technique of representing the data as curves (rather than as a series of discrete, static points) encourages the belief that there are dependent relationships between PRA, MCFP, and venous return. In one critic's words, 'in that model ... venous return is driven through a fixed hydraulic resistor connected between a pressure source fixed at MCFP and an independently variable "back pressure" PRA. ... this practice of taking the components of the model as having actual counterparts in the vasculature confuses a mathematical abstraction with reality' [1]. Additionally, Guyton did not clarify how his model might explain what occurs when cardiac output is on the flat portion of the cardiac function curve. In this situation, both PRA and MCFP may rise without a change in cardiac output.

Recent studies

Until recently, the measurement of venous return curves in a functioning human cardiovascular system was elusive. Schipke and colleagues [35] measured MCFP in humans during cardiac arrest -- an artificial circumstance. Jellinek and colleagues [36] studied the effect of increases in airway pressure on venous return in patients with iatrogenic ventricular fibrillation during pacemaker implantation. Increases in airway pressure decreased cardiac output but did cause equal increases in PRA and MCFP. Thus, decreases in cardiac output did not appear to be from decreases in the venous pressure gradient but rather from increases in resistance to venous return.

In the past year, Maas and colleagues [37] reported the first measurements of human venous return curves in intact human circulation. The authors estimated PRA by measuring CVP and estimated venous return by measuring cardiac output using pulse contour analysis. During apnea at a variety of inspiratory pressures on mechanical ventilation, Maas and colleagues constructed venous return curves in individual patients. In a confirmation of Guyton's theoretical and animal work, the authors found surprisingly linear venous return curves and found that MCFP changed as predicted by Guyton. However, the estimate of MCFP in this study was 18.8 mm Hg in euvolemic supine patients. This is considerably higher than previous estimates [22, 23, 35]. It is unclear whether this may have been due to the experimental protocol or to patient characteristics (the subjects were post-cardiac surgery patients and conceivably had high right-sided cardiac filling pressures due to chronic or post-operative decreased ventricular function). Despite these concerns, the work by Maas and colleagues [37] lends considerable 'real world' support to the use of Guyton's model in intact human subjects.

Conclusions

Arthur Guyton's model of cardiac output governed by the relationship between PRA values and the MCFP has simultaneously confused and clarified thinking about cardiac physiology for half a century. That his insights continue to inform debate is a testament to the flexibility and utility of his model. However, it is critical to remember that his model is simply that: an approximation of reality, not reality itself. Despite recent human evidence that supports Guyton's model, several valid concerns about the experimental preparations from which his concepts derive and about the interpretation of his data exist.